FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth.

[1]  D. Foell,et al.  S100A9 extends lifespan in insulin deficiency , 2019, Nature Communications.

[2]  Gang Chen,et al.  Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer , 2019, Oncology reports.

[3]  P. Baldi,et al.  Light Entrains Diurnal Changes in Insulin Sensitivity of Skeletal Muscle via Ventromedial Hypothalamic Neurons. , 2019, Cell reports.

[4]  K. Kerr,et al.  Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC , 2019, Nature Reviews Clinical Oncology.

[5]  James C. Hu,et al.  The Gene Ontology Resource: 20 years and still GOing strong , 2019 .

[6]  L. Montanaro,et al.  The Ribosome Biogenesis—Cancer Connection , 2019, Cells.

[7]  The Gene Ontology Consortium,et al.  The Gene Ontology Resource: 20 years and still GOing strong , 2018, Nucleic Acids Res..

[8]  J. Wolchok,et al.  Putting the Immunologic Brakes on Cancer , 2018, Cell.

[9]  L. Paz-Ares,et al.  KRAS-Mutant non-small cell lung cancer: From biology to therapy. , 2018, Lung cancer.

[10]  Iñigo Apaolaza,et al.  CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets. , 2018, Cancer research.

[11]  A. Lánczky,et al.  Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets , 2018, Scientific Reports.

[12]  S. Vicent,et al.  KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target , 2018, Molecular Cancer.

[13]  Fabio Lauria,et al.  riboWaltz: Optimization of ribosome P-site positioning in ribosome profiling data , 2017, bioRxiv.

[14]  Jaeho Bae,et al.  Enhancement of antitumor immunity by combination of anti-CTLA-4 antibody and radioimmunotherapy through the suppression of Tregs. , 2017, Oncology letters.

[15]  M. Yamauchi,et al.  FKBP65-dependent peptidyl-prolyl isomerase activity potentiates the lysyl hydroxylase 2-driven collagen cross-link switch , 2017, Scientific Reports.

[16]  P. Baldi,et al.  SIRT6 Suppresses Cancer Stem-like Capacity in Tumors with PI3K Activation Independently of Its Deacetylase Activity , 2017, Cell reports.

[17]  J. Settleman,et al.  Proline Starvation Induces Unresolved ER Stress and Hinders mTORC1-Dependent Tumorigenesis. , 2016, Cell metabolism.

[18]  Kol Jia Yong,et al.  Targeting SALL4 by entinostat in lung cancer , 2016, Oncotarget.

[19]  Song Wu,et al.  FK506 Binding Protein 10 Is Overexpressed and Promotes Renal Cell Carcinoma , 2016, Urologia Internationalis.

[20]  L. Paz-Ares,et al.  Current Challenges in Cancer Treatment. , 2016, Clinical therapeutics.

[21]  Reuven Agami,et al.  Tumour-specific proline vulnerability uncovered by differential ribosome codon reading , 2016, Nature.

[22]  Gunnar Rätsch,et al.  RiboDiff: detecting changes of mRNA translation efficiency from ribosome footprints , 2015, bioRxiv.

[23]  R. Coppari,et al.  Enhanced insulin sensitivity in skeletal muscle and liver by physiological overexpression of SIRT6 , 2015, Molecular metabolism.

[24]  G. Massonnet,et al.  Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists , 2013, Nature.

[25]  N. Sonenberg,et al.  Targeting the translation machinery in cancer , 2015, Nature Reviews Drug Discovery.

[26]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[27]  R. Coppari,et al.  Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis , 2015, Cell metabolism.

[28]  Michael N. Hall,et al.  mTORC1 mediated translational elongation limits intestinal tumour initiation and growth , 2014, Nature.

[29]  Brendan H. Lee,et al.  Connective tissue alterations in Fkbp10-/- mice. , 2014, Human molecular genetics.

[30]  R. Weinberg,et al.  Tackling the cancer stem cells — what challenges do they pose? , 2014, Nature Reviews Drug Discovery.

[31]  A. Koromilas,et al.  Translational Control during Endoplasmic Reticulum Stress beyond Phosphorylation of the Translation Initiation Factor eIF2α* , 2014, The Journal of Biological Chemistry.

[32]  P. Rosenstiel,et al.  XIAP variants in male Crohn's disease , 2014, Gut.

[33]  A. Mes-Masson,et al.  FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome. , 2013, International journal of oncology.

[34]  Shu-Bing Qian,et al.  Cotranslational response to proteotoxic stress by elongation pausing of ribosomes. , 2013, Molecular cell.

[35]  I. Wistuba,et al.  RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas. , 2013, Cancer discovery.

[36]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[37]  P. Beighton,et al.  Mutations in FKBP10 Cause Recessive Osteogenesis Imperfecta and Bruck Syndrome , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  P. Byers,et al.  Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. , 2010, American journal of human genetics.

[39]  P. Byers,et al.  Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. , 2010, American journal of human genetics.

[40]  C. Iacobuzio-Donahue,et al.  Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. , 2010, Journal of the National Cancer Institute.

[41]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[42]  D. Steindler,et al.  Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. , 2009, Cancer research.

[43]  K. Yasumoto,et al.  Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer , 2009, General thoracic and cardiovascular surgery.

[44]  H. Burris,et al.  Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs , 2009, Oncogene.

[45]  Nicholas T. Ingolia,et al.  Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling , 2009, Science.

[46]  Y. Ishikawa,et al.  The Rough Endoplasmic Reticulum-resident FK506-binding Protein FKBP65 Is a Molecular Chaperone That Interacts with Collagens* , 2008, Journal of Biological Chemistry.

[47]  K. Myers,et al.  The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin. , 2008, International journal of oncology.

[48]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[49]  A. Bhandoola,et al.  Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. , 2007, Cell stem cell.

[50]  A. Cheung,et al.  Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential , 2007, Leukemia.

[51]  J. Dick,et al.  Cancer stem cells: lessons from leukemia. , 2005, Trends in cell biology.

[52]  Danila Coradini,et al.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.

[53]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[54]  T. Ørntoft,et al.  Human FK506 Binding Protein 65 Is Associated with Colorectal Cancer*S , 2005, Molecular & Cellular Proteomics.

[55]  H. Varmus,et al.  KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib , 2005, PLoS medicine.

[56]  T. Honjo,et al.  PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. , 2004, International immunology.

[57]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[58]  H. Varmus,et al.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.

[59]  C. Holding,et al.  Human embryonic genes re-expressed in cancer cells , 2001, Oncogene.

[60]  E. Davis,et al.  Developmental regulation of FKBP65. An ER-localized extracellular matrix binding-protein. , 2000, Molecular biology of the cell.

[61]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[62]  G. Rall,et al.  Measles Virus Spread between Neurons Requires Cell Contact but Not CD46 Expression, Syncytium Formation, or Extracellular Virus Production , 2000, Journal of Virology.

[63]  M. Ashburner,et al.  The Gene Ontology Consortium , 2000 .

[64]  J. Allison,et al.  Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.

[65]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.